Suzhou Highfine Biotech Co Ltd (SZSE:301393) Share Price

Company Profile

Business description
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Contact
No. 32 Hongxi Road
F-12 Standard Factory Building
High-tech Zone, Jiangsu Province
Suzhou215151
CHN
T: +86 51265399366
https://www.highfine.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
428

Recommended

We see faster cloud growth and improved longer-term profitability for Alphabet.

Malik Ahmed Khan, CFA | 25 October 2025

Solid start to 2026 but shares overvalued.

Jon Mills, CFA | 24 October 2025

With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.

Dan Romanoff, CPA | 23 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,317.20	26.50	-0.28%
CAC 40	8,225.63	0.15	-0.00%
DAX 40	24,239.89	32.10	0.13%
Dow JONES (US)	47,207.12	472.51	1.01%
FTSE 100	9,645.62	67.05	0.70%
HKSE	26,160.15	192.17	0.74%
NASDAQ	23,204.87	263.07	1.15%
Nikkei 225	49,299.65	658.04	1.35%
NZX 50 Index	13,391.59	14.49	0.11%
S&P 500	6,791.69	53.25	0.79%
S&P/ASX 200	9,019.00	25.20	-0.28%
SSE Composite Index	3,950.31	27.90	0.71%